CP lacking vWF contains an equivalent amount of ADAMTS13 to FFP or its derivative and is considered a better choice than other plasma products, such as FFP, for TPE in patients with TTP [1–3]. This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.